$0.7518
-0.00330-0.44%
At close: -
$0.7518
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Cue Biopharma Earnings Estimates, EPS & Revenue | NASDAQ:CUE | Benzinga
Cue Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS Estimate
$-0.120
Quarterly Revenue Estimate
$901.50K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$9.29M
Analyze the earnings history of Cue Biopharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CUE | Cue Biopharma | -$0.25 | -$0.12 | — | — | $1.72M | $901.50K | — | — | 05/12/2025 | Get Alert |
| CUE | Cue Biopharma | -$0.29 | -$0.14 | -$0.13 | 7.14% | $1.82M | $1.70M | $1.58M | -7.29% | 03/31/2025 | Get Alert |
| CUE | Cue Biopharma | -$0.24 | -$0.19 | -$0.17 | 10.53% | $2.10M | $1.52M | $3.34M | 119.47% | 11/14/2024 | Get Alert |
| CUE | Cue Biopharma | -$0.29 | -$0.29 | -$0.20 | 31.03% | $1.38M | $1.29M | $2.66M | 106.05% | 08/14/2024 | Get Alert |
| CUE | Cue Biopharma | -$0.29 | -$0.28 | -$0.25 | 10.71% | $187.00K | $1.21M | $1.72M | 41.90% | 05/09/2024 | Get Alert |
| CUE | Cue Biopharma | -$0.37 | -$0.28 | -$0.28 | 0.00% | $151.00K | $1.71M | $1.82M | 6.49% | 04/08/2024 | Get Alert |
| CUE | Cue Biopharma | -$0.31 | -$0.34 | -$0.24 | 29.41% | $68.00K | $1.13M | $2.10M | 85.84% | 11/03/2023 | Get Alert |
| CUE | Cue Biopharma | -$0.37 | -$0.30 | -$0.29 | 3.33% | $26.00K | $1.21M | $1.38M | 14.21% | 08/09/2023 | Get Alert |
| CUE | Cue Biopharma | -$0.44 | -$0.29 | -$0.29 | 0.00% | $1.00M | $1.95M | $187.00K | -90.41% | 05/09/2023 | Get Alert |
| CUE | Cue Biopharma | -$0.25 | -$0.31 | -$0.37 | -19.35% | $8.25M | $100.00K | $151.00K | 51.00% | 03/21/2023 | Get Alert |
| CUE | Cue Biopharma | -$0.41 | -$0.38 | -$0.31 | 18.42% | $2.40M | $440.00K | $68.00K | -84.55% | 11/14/2022 | Get Alert |
| CUE | Cue Biopharma | -$0.33 | -$0.42 | -$0.37 | 11.90% | $2.74M | — | $26.00K | — | 08/04/2022 | Get Alert |
| CUE | Cue Biopharma | -$0.41 | -$0.43 | -$0.44 | -2.33% | $1.55M | $3.05M | $1.00M | -67.21% | 05/10/2022 | Get Alert |
| CUE | Cue Biopharma | -$0.36 | -$0.38 | -$0.25 | 34.21% | $475.00K | — | $8.25M | — | 03/16/2022 | Get Alert |
| CUE | Cue Biopharma | -$0.34 | -$0.39 | -$0.41 | -5.13% | $704.00K | — | $2.40M | — | 10/27/2021 | Get Alert |
| CUE | Cue Biopharma | -$0.38 | -$0.42 | -$0.33 | 21.43% | $1.07M | $1.06M | $2.74M | 158.40% | 08/17/2021 | Get Alert |
| CUE | Cue Biopharma | -$0.48 | -$0.38 | -$0.41 | -7.89% | $900.00K | — | $1.55M | — | 05/17/2021 | Get Alert |
| CUE | Cue Biopharma | -$0.37 | -$0.35 | -$0.37 | -5.71% | $1.05M | $1.33M | $475.00K | -64.29% | 03/16/2021 | Get Alert |
| CUE | Cue Biopharma | -$0.31 | — | -$0.34 | — | $984.00K | — | $704.00K | — | 11/09/2020 | Get Alert |
| CUE | Cue Biopharma | -$0.46 | — | -$0.38 | — | $1.05M | — | $1.07M | — | 08/10/2020 | Get Alert |
| CUE | Cue Biopharma | -$0.54 | — | -$0.48 | — | $370.00K | — | $900.00K | — | 05/19/2020 | Get Alert |
Cue Biopharma (CUE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-31 | $-0.13 | $-0.14 | 7.14 % |
| Q3 | 2024-11-14 | $-0.17 | $-0.19 | 10.5 % |
| Q2 | 2024-08-14 | $-0.20 | $-0.29 | 31.0 % |
| Q1 | 2024-05-09 | $-0.25 | $-0.28 | 10.7 % |
Cue Biopharma (CUE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-31 | $1.58M | $1.70M | -7.29 % |
| Q3 | 2024-11-14 | $3.34M | $1.52M | 119.5 % |
| Q2 | 2024-08-14 | $2.66M | $1.29M | 106.0 % |
| Q1 | 2024-05-09 | $1.72M | $1.21M | 41.9 % |
FAQ
When is Cue Biopharma (NASDAQ:CUE) reporting earnings?
Cue Biopharma (CUE) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 31, 2025 for Q4.
What were the latest earnings per share (EPS) for Cue Biopharma (NASDAQ:CUE)?
The Actual EPS was $-0.13, which beat the estimate of $-0.14.
What were Cue Biopharma’s (NASDAQ:CUE) revenues?
The Actual Revenue was $1.6M, which missed the estimate of $1.7M.
Browse earnings estimates, EPS, and revenue on all stocks.
